Author Topic: (Abst.) Gray matter atrophy in MS despite clinical and lesion stability during Tysabri treatment  (Read 70 times)

0 Members and 0 Guests are viewing this topic.

Offline agate

  • Administrator
  • *****
  • Posts: 8244
  • MS diagnosed 1980
  • Location: Pacific Northwest
From PubMed, December 23, 2018--"Gray matter atrophy in multiple sclerosis despite clinical and lesion stability during natalizumab treatment":


https://www.ncbi.nlm.nih.gov/pubmed/30576361
MS Speaks--online for 13 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010.

Offline agate

  • Administrator
  • *****
  • Posts: 8244
  • MS diagnosed 1980
  • Location: Pacific Northwest
MS Speaks--online for 13 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010.

 

Related Topics

  Subject / Started by Replies Last post
0 Replies
81 Views
Last post April 07, 2016, 02:12:24 pm
by agate
0 Replies
46 Views
Last post April 26, 2017, 07:09:59 am
by agate
0 Replies
46 Views
Last post December 24, 2017, 02:04:09 pm
by agate
0 Replies
63 Views
Last post March 16, 2018, 11:51:28 am
by agate
0 Replies
33 Views
Last post July 06, 2018, 09:20:12 pm
by agate